Tacrolimus and Neoplasm recurrence - a phase IV clinical study of FDA data

Summary:

Neoplasm recurrence is reported as a side effect among people who take Tacrolimus (tacrolimus), especially for people who are female, 60+ old, have been taking the drug for 10+ years also take Methylprednisolone, and have Immunodeficiency disorders.

The phase IV clinical study analyzes which people have Neoplasm recurrence when taking Tacrolimus. It is created by eHealthMe based on reports of 115,828 people who have side effects when taking Tacrolimus from the FDA, and is updated regularly.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

What is Neoplasm recurrence?

Neoplasm recurrence (reoccurrence of tumour) is found to be associated with 362 drugs and 494 conditions by eHealthMe. Check the latest studies of Neoplasm recurrence.

On Jul, 13, 2026

115,828 people reported to have side effects when taking Tacrolimus.
Among them, 41 people (0.04%) have Neoplasm recurrence.

Could Tacrolimus cause Neoplasm recurrence?

Among these 41 people:

How long have people been on Tacrolimus when they have Neoplasm recurrence? *

What is the gender of people who have Neoplasm recurrence when taking Tacrolimus? *

female: 58.62 %
male: 41.38 %

What is the age of people who have Neoplasm recurrence when taking Tacrolimus? *

What are other drugs people take besides Tacrolimus? *

Mycophenolate Mofetil: 15 people, 36.59%
Methylprednisolone: 15 people, 36.59%
Cellcept: 3 people, 7.32%
Prednisone: 3 people, 7.32%
Vitamin D: 2 people, 4.88%
Mycophenolic Acid: 2 people, 4.88%
Gemcitabine: 2 people, 4.88%
Glycopyrrolate: 1 person, 2.44%
Aspirin: 1 person, 2.44%
Bactrim: 1 person, 2.44%

What are other side effects people have besides Neoplasm recurrence? *

Metastases To Spine (cancer spreads to spine): 11 people, 26.83%
Metastases To Bone (cancer spreads to bone): 11 people, 26.83%
Metastases To Lung (cancer spreads to lung): 11 people, 26.83%
Squamous Cell Carcinoma Of Skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin): 11 people, 26.83%
Metastases To Pleura (cancer spreads to pleura): 10 people, 24.39%
Metastases To Lymph Nodes (cancer spreads to lymph node): 10 people, 24.39%
Sepsis (a severe blood infection that can lead to organ failure and death): 7 people, 17.07%
Pneumonia: 4 people, 9.76%
Drug Ineffective: 4 people, 9.76%
Infection: 3 people, 7.32%

What are the existing conditions these people have? *

Immunodeficiency Disorders: 5 people, 12.20%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 1 person, 2.44%
Depression: 1 person, 2.44%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 2.44%
Affective Disorder (mental disorder): 1 person, 2.44%
Bacterial Infection: 1 person, 2.44%
Bone Disorder: 1 person, 2.44%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 1 person, 2.44%
Burkitt's Lymphoma (cancer of the lymphatic system): 1 person, 2.44%
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 1 person, 2.44%

* Approximation only. Some reports may have incomplete information.

Do you take Tacrolimus and have Neoplasm recurrence?

- Check whether Neoplasm recurrence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tacrolimus:

Tacrolimus (116,160 reports)

Browse all side effects of Tacrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neoplasm recurrence:

Neoplasm recurrence (362 drugs)

Browse all the conditions that are associated with Neoplasm recurrence:

Neoplasm recurrence (494 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Tacrolimus) and Tacrolimus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.